Vinh Vu

Neoadjuvant Osimertinib for Resectable <i>EGFR</i> -Mutated Non–Small Cell Lung Cancer

Jianxing He, Masahiro Tsuboi, Walter Weder et al. · Journal of Clinical Oncology · 2025 · 61 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis

Mei–Hsuan Lee, Tiffany I. Hsiao, Shreenidhi R. Subramaniam et al. · The American Journal of Gastroenterology · 2017 · 60 citations

Medicine, Infectious Diseases, Oncology +17

Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis

Joseph Hoang, Hwai‐I Yang, An K. Le et al. · Medicine · 2016 · 50 citations · Full text

Medicine, Oncology, Pharmacology +15

Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B

C. Wang, Vincent Chen, Vinh Vu et al. · Medicine · 2016 · 39 citations · Full text

Medicine, Oncology, Disease Surveillance +16

Poor Sustained Virological Response in a Multicenter Real-Life Cohort of Chronic Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin plus Telaprevir or Boceprevir

Kevin Vo, Philip Vutien, Matthew J. Akiyama et al. · Digestive Diseases and Sciences · 2015 · 28 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17